Bio News
Seegene reported second-quarter operating profit of 21.5 billion won, up 586.4% from the same period a year earlier. Revenue for the same period rose 19.2% year over year to 135.9 billion won. Seegene reported cumulative operating profit of 45.1 billion won for the first half, an increase of 150.9% from the same period a year earlier.
BIOBOOK TEAM
biobookmedia@biobook.co.krParagon Spin-Off Velaris Goes Public Through Reverse Merger With Alaunos
Syndax halts development of Niktimvo for pulmonary fibrosis; shares plunge 17%
BioNTech’s mRNA Cancer Vaccine Misses Primary Endpoint for Progression-Free Survival in Phase 3 Trial
Roche Signs $1.6 Billion Deal With China’s Rona for ALK7 Obesity Drug
Formycon and Zydus’ Keytruda Biosimilar Is First to Be Accepted for FDA Review
Pfizer Signs $500 Million Protein Degrader Deal With Enodia
